Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003447417 | SCV005838002 | uncertain significance | Charcot-Marie-Tooth disease dominant intermediate B | 2024-03-07 | criteria provided, single submitter | clinical testing | This variant results in the deletion of c.1885_1893+8del of the DNM2 gene. RNA analysis indicates that this variant induces altered splicing and likely results in the gain of 23 amino acid residue(s), but is expected to preserve the integrity of the reading-frame. This variant is not present in population databases (gnomAD no frequency). This variant has been observed in individual(s) with autosomal dominant centronuclear myopathy and/or DNM2-related conditions (PMID: 22396310, 37273706). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 2664457). Studies have shown that this variant results in the activation of a cryptic splice site in intron 17 (PMID: 22396310). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Inherited Neuropathy Consortium Ii, |
RCV003447417 | SCV004174769 | uncertain significance | Charcot-Marie-Tooth disease dominant intermediate B | 2016-01-06 | no assertion criteria provided | literature only |